Ignyta to Present at 28th Annual Piper Jaffray Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused
on precision medicine in oncology, announced today that Jacob Chacko,
M.D., its Chief Financial Officer, will make a presentation at the 28^th
Annual Piper Jaffray Healthcare Conference on Tuesday, November 29,
2016, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) in New York
City.

A webcast of the presentation will be available during the presentation
in the Investors section of the company’s website at https://www.ignyta.com/investors/,
and will be archived and available at that site for 14 days.

About Ignyta, Inc.

Blazing a New Future for Patients with Cancer™

At Ignyta, we work tirelessly on behalf of patients with cancer to offer
potentially life-saving, precisely targeted therapeutics (Rx) guided by
companion diagnostic (Dx) tests. Our integrated Rx/Dx strategy allows us
to enter uncharted territory, illuminating the molecular drivers of
cancer and quickly advancing treatments to address them. This approach
embraces even those patients with the rarest cancers, who have the
highest unmet need and who may otherwise not have access to effective
treatment options. With our pipeline of potentially first-in-class and
best-in-class precision medicines, we are pursuing the ultimate goal of
not just shrinking tumors, but eradicating cancer relapse and recurrence
in precisely defined patient populations.

For more information, please visit: www.ignyta.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161122005338/en/